Neal Clifton Bradsher
Independent Chairman of the BoardMr. Neal Clifton Bradsher, CFA, serves as the President and Chief Compliance Officer at Broadwood Capital, Inc. Mr. Bradsher is Independent Chairman of the Board of STAAR Surgical Company from January 15, 2026. Mr. Bradsher also serves as the President of the general partner of Broadwood Partners, L.P. He has a wealth of experience in finance, management and corporate governance attained through his successful investments in other companies, including companies in the pharmaceutical, medical device, health care services and health care information systems sectors. He worked with several health care companies to improve their management and governance. Mr. Bradsher founded Broadwood Capital in 2002. He served as a Portfolio Manager at two investment management firms, Whitehall Asset Management, Inc. from 1999 to 2002 and Campbell Advisors, Inc. from 1994 to 1999. Mr. Bradsher served as a Healthcare Equity Analyst at Deutsche Bank Alex. Brown Inc., Research Division, Deutsche Bank AG, Research Division and JP Morgan Chase & Co, Research Division. He served as senior equity analyst at Alex Brown & Sons and Hambrecht & Quist. Mr. Bradsher serves as an Independent Director of Lineage Cell Therapeutics, Inc. (formerly known as BioTime, Inc.) since July 2009. He joined the Lineage Cell Therapeutics, Inc. in July 2009. He served as a Director of Questcor Pharmaceuticals, Inc. since March 17, 2004 until August 2014 and served as its Lead Director from May 2004 to October 2004. Mr. Bradsher served as a Director at two investment management firms, Whitehall Asset Management, Inc. from 1999 to 2002 and Campbell Advisors, Inc. from 1994 to 1999. He is a Chartered Financial Analyst. Mr. Bradsher holds B.A. in Economics from Yale College.
Positions
- Company NameSTAAR Surgical CompanyStock CodeSTAAPositionIndependent Chairman of the BoardColleagues
- WFWarren FoustCEO, President & Director
- DJDeborah J. AndrewsExecutive VP & CFO
- MMMagda MichnaChief Development Officer
- BPBen ParkChief Technology Officer
- CJConnie JohnsonDirector of Investor Relations
- LELouis E. SilvermanIndependent Director
- LYLilian Y. ZhouIndependent Director
- BWBrian WilliamsMember of Optometric Advisory Council
- Company NameLineage Cell Therapeutics, Inc.Stock CodeLCTXPositionIndependent DirectorColleagues
- BMBrian M. CulleyCEO, President & Director
- MHMichael H. MulroyIndependent Chairman
- JAJill Ann HoweChief Financial Officer
- GAGeorge A. SamuelGeneral Counsel & Company Secretary
- ICIoana C. HoneVP of Corporate Communications & Director of Investor Relations
- CHCharlotte HubbertVice President of Corporate Strategy & Development
- NCNeal Clifton BradsherIndependent Director
- DJDeborah J. AndrewsIndependent Director
- ACAngus C. RussellIndependent Director
